Aligos Therapeutics, Inc.
ALGSNasdaqCIK 1799448HealthcareFiscal year ends Dec 31
Reports and events: 101 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2020-09-2517:27 ET | S-1 | Registration statement | 0001193125-20-254760 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 12:13 ET. Listed shows no prices and gives no investment advice.